5-hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone has been researched along with Osteosarcoma in 1 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vansteelandt, M | 1 |
Blanchet, E | 1 |
Egorov, M | 1 |
Petit, F | 1 |
Toupet, L | 1 |
Bondon, A | 1 |
Monteau, F | 1 |
Le Bizec, B | 1 |
Thomas, OP | 1 |
Pouchus, YF | 1 |
Le Bot, R | 1 |
Grovel, O | 1 |
1 other study available for 5-hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone and Osteosarcoma
Article | Year |
---|---|
Ligerin, an antiproliferative chlorinated sesquiterpenoid from a marine-derived Penicillium strain.
Topics: Antineoplastic Agents; Cyclohexanes; Drug Screening Assays, Antitumor; Estuaries; Fatty Acids, Unsat | 2013 |